Archive - September 2024
Korro Bio and Novo Nordisk Collaborate on Cardiometabolic Treatments
Recipharm Investment Will Enhance Oral Solid Development, GMP Pilot-Scale Suites
Lilly’s $1.8 Billion Biologics Expansion Expected to Grow Manufacturing Footprint in Ireland
Validating Pharma 4.0 for Smart Manufacturing
Discussing Downstream Bioprocessing Innovations that are Enhancing Manufacturing Efficiencies (BIO 2024)
Novo Nordisk, NanoVation Enter $600M Genetic Medicine Partnership
Phillips Medisize to Acquire Vectura, Expanding Inhalation Drug Delivery Capabilities
Adare, Laxxon to Collaborate on 3D-Printed Oral Dosage Forms